Summary
Some murine strains are characterized by a high susceptibility to both spontaneous and carcinogen-induced hepatocarcinogenesis (C3H, CF-1, CBA), whereas other strains are resistant (C57BL/6, BALB/c). The liver carcinogenesis process, as well as carcinogenesis in other organs, is not a single step process, but involves multiple steps leading from the normal hepatocyte to the hepatocellular carcinoma. Therefore, genetic differences between murine strains may reside in genetic loci controlling either initiation or promotion/progression stages. We have observed, using a medium-term liver carcinogenesis bioassay and stereological analysis, that the total number of NDEA-induced liver-nodules/cm3 was about the same in a susceptible F1 hybrid (B6C3) and in a resistant one (B6C), indicating that both hybrids were equally sensitive to NDEA-initiation. However, the size of the nodules was much larger in the susceptible compared to the resistant hybrid. Therefore, we proposed that a major difference is not in the susceptibility to initiation, but in the susceptibility to progression. The hepatocytes, once initiated, grow, progress, and give rise to grossly evident tumors more efficiently and more rapidly in the susceptible than in the resistant strain. In a subsequent study we have treated B6C3F2 mice with NDEA and then measured liver nodule frequency and size, using stereological analysis. We have found that almost all mice had a similar total number of nodules/cm3. However, when the size distribution of nodules was analysed, the F2 population could be easily divided into two subgroups. The subgroups identified a population of resistant mice and another one of susceptible mice. The percentage of resistant mice was in agreement with the hypothesis that a single genetic locus accounts for the major part of the difference in the susceptibility to progression between C3H/He and C57BL/6 mice.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J. M. Adams, A. W. Harris, C. A. Pinkert, L. M. Corcoran, W. S. Alexander, S. Cory, R. D. Palmiter, and R. L. Brinter, The c-myc oncogene driven by immonoglobulin enhancers induces lymphoid malignancy in transgenic mice, Nature 318:533 (1985).
F. F. Becker, Morphological classification of mouse liver tumors based on biological characteristic, Cancer Res. 42:3918 (1982).
F. F. Becker, Tumor phenotype and susceptibility to progression as an expression of subpopulation of initiated murine cells, Cancer Res. 45:768 (1985).
F. F. Becker, Progression of tumor histiotype during mouse hepatocarcinogenesis associated with the viable yellow (AVY) gene, Cancer Res. 46:2241 (1986).
M. Breuer, R. Slebos, S. Verbeek, M. van Lohuizen, E. Wientjens, A. Berns, Predisposition of pim-1 transgenic mice to ENU-induced lymphomagenesis. Fifth Annual Meeting on Oncogenes, Frederick, MD, Book of Abstracts, 381, (1989).
B. R. Davis, B. K. Brightman, K. G. Chandy, and H. Fan, Characterization of a preleukemic state induced by Moloney murine leukemia virus: Evidence for two infection events during leukemogenesis, Proc. Natl. Acad. Sci. 84:4875 (1987).
G. Della Porta, J. Capitano, L. Parmi, M. I. Colnaghi, Cancerogenesi da uretano in topi neonati, lattanti ed adulti dei ceppi C57BL, C3H, BC3F1, C3Hf e SWR, Tumori 53:81 (1967).
H. K. De Munter, L. Den Engelse, and P. Emmelot, Studies on lung tumours. IV. Correlation between [3H]thymidine labelling of lung and liver cells and tumour formation in GRS/A and CH3f/A male mice following administration of dimethylnitrosamine, Chem. Biol. Interactions 24:299 (1979).
T. A. Dragani, G. Sozzi, and G. Della Porta, Spontaneous and urethan-induced tumor incidence in B6C3F1 versus B6CF1 mice, Tumori 70:485 (1984).
T. A. Dragani, G. Manenti, and G. Della Porta, Genetic susceptibility to murine hepatocarcinogenesis is associated with high growth rate of NDEA-initiated hepatocytes, J. Cancer Res. Clin. Oncol. 113:223 (1987).
N. R. Drinkwater, and J. J. Ginsler, Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice, Carcinogenesis 7:1707 (1986).
P. H. Duesberg, Retrovirus as carcinogens and pathogens: expectations and reality, Cancer Res. 47:1199 (1987).
E. Farber, Cellular biochemistry of the stepwise development of cancer with chemicals: G.H.A. Clowes Memorial Lecture, Cancer Res. 44:5463 (1984).
M. Festing, “Inbred Strains in Biomedical Research,” Oxford University Press, New York (1979).
D. Hanahan, Dissecting multistep tumorigenesis in trasgenic mice, Ann. Rev. Genet. 22:479 (1988).
M. H. Hanigan, C. J. Kemp, J. J. Ginsler, and N. R. Drinkwater, Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice, Carcinogenesis 9:885 (1988).
J. W. Hartley, N. K. Wolford, L. J. Old, and W. P. Rowe, A new class of murine leukemia virus associated with development of spontaneous lymphomas, Proc. Natl. Acd. Sci. USA 74:789 (1977).
W. S. Hayward, B. G. Neel, and S. M. Astrin, Activation of a cellular oncogene by promoter insertions in ALV-induced lymphoid leukosis, Nature 290:475 (1981).
W. A. Held, J. J. Mullins, N. J. Kuhn, J. F. Gallagher, G. D. Gu, and K. W. Gross, T antigen expression and tumorigenesis in transgenic mice containing a mouse major urinary protein/SV40 T antigen hybrid gene, EMBO J. 8:183 (1989).
J. Hilgers, and P. Bentvelzen, Interaction between viral and genetic factors in murine mammary cancer, Adv. Cancer Res. 26:143 (1978).
N. E. Hynes, B. Groner, and R. Michalides, Mouse mammary tumor virus: transcriptional control and involvement in tumorigenesis, Adv. Cancer Res. 41:155 (1984).
N. A. Jenkins, and N. G. Copeland, Transgenic mice in cancer research, Important Adv. Oncol. 61–77 (1989).
H. Land, L. Parada, and R. A. Weinberg, Tumorigenic conversion of primary embryo fibroblasts requires at least two co-operating oncogenes, Nature 304:596 (1983).
J. C. Lee, and J. N. Ihle, Chronic immune stimulation is required for Moloney leukemia virus-induced lymphomas, Nature 289: 407 (1981)
F. Lilly, and T. Pincus, Genetic control of murine viral leukemogenesis, Adv. Cancer Res. 17:231 (1973).
F. Lilly, M. L. Duran-Reynals, and W. P. Rowe, Correlation of early murine leukemia virus titer and H2 type with spontaneous leukemia in mice of the BALB/c x AKR cross: A genetic analysis, J. Exp. Med. 141:882 (1975).
A. M. Malkinson, M. N. Nesbitt, and E. Skamene, Susceptibility to urethan-induced pulmonary adenomas between A/J and C57BL/6J mice: use of AXB and BXA recombinant inbred lines indicating a three-locus genetic model, J. Natl. Cancer Inst. 75:971 (1985)
D. Meruelo, and R. Bach, Genetics of resistance to virus-induced leukemias, Adv. Cancer Res. 40:107 (1983).
A. Messing, H. Y. Chen, R. D. Palmiter, and R. L. Brinster, Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice, Nature 316:461 (1985).
M. Naito, K. J. Chenicek, Y. Naito, and J. DiGiovanni, Susceptibility to phorbol ester skin tumor promotion in (C57BL/6 x DBA/2)F1 mice is inherited as an incomplete dominant trait: evidence for multi-locus involvement, Carcinogenesis 9:639 (1988).
S. Nandi, and C. M. McGrath, Mammary neoplasia in mice, Adv. Cancer Res. 17:353 (1973).
R. Nusse, and H. E. Varmus, Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome, Cell. 31:99 (1982).
R. D. Palmiter, and R. L. Brinster, Germ-line transformation of mice, Ann. Rev. Genet. 20:465 (1986).
V. K. Pathak, R. Strange, L. J. T. Young, D. W. Morris, and R. D. Cardiff, Survey of int region DNA rearrangements in C3H and BALB/cfC3H mouse mammary tumor system, J. Natl. Cancer Inst. 78:327 (1987).
G. Peters, S. Brookes, R. Smith, et al., Tumorigenesis by mouse mammary tumor virus: Evidence for a common region for provirus integration in mammary tumors, Cell. 33:369 (1983).
R. Peto, Epidemiology, multistage models, and short-term mutagenicity tests, in: “Origins of Human Cancer,” H. H. Hiatt, J. D. Watson, and J. A. winsten, eds., Cold Spring Harbor Press, New York (1977).
H. C. Pitot. Progression: The terminal stage in carcinogenesis, Jpn. J. Cancer Res. 80:599 (1989).
T. D. Pugh, J.H. King, H. Koen, D. Nychka, J. Choyer, G. Wahba, Y. He, and S. Goldfarb, Reliabe stereological method for estimating the number of microscopic hepatocellular foci from their transections, Cancer Res. 43:1261 (1983).
s. H. Reynolds, S. J. Stowers, R. M. Patterson, R. R. Maronpot, S. A. Aaronson, and M. W. Anderson, Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment, Science 237:1309 (1987).
R. Risser, J. M. Horowitz, and J. Mccubrey, Endogenous mouse leukemia viruses, Ann. Rev. Genet. 17:85 (1983).
W. P. Rowe, J. W. Hartley, and T. Bremner, Genetic mapping of a murine leukemia virus-inducing locus of AKR mice, Science 178:860 (1972).
W. P. Rowe, and T. Pincus, Quantitative studies of naturally occuring murine leukaemia virus infection of AKR mice, J. Exp. Med. 135:429 (1972).
E. P. Sandgren, C. J. Quaife, C. A. Pinkert, R. D. Palmiter, and R. L. Brinster, Oncogene-induced liver neoplasia in transgenic mice, Oncogene 4:715 (1989).
R. C. Seeger, G. M. Brodeur, H. Sather, A. Dalton, S. E. Siegel, K. Y. Wong, and D. Hammond, Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas, N. Engl. J. Med. 313:1111 (1985).
G. Selten, H. T. Cuypers, M. Zijlstra, C. Melif, and A. Berns, Involvement of c-myc in MuLV-induced T cell lymphomas in mice: frequency and mechanisms of activation, EMBO J. 3:3215 (1984).
G. Selten, H. T. Cuypers, and A. Berns, Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas, EMBO J. 4:1793 (1985).
P. Shubik, Progression and promotion, J. Natl. Cancer Inst. 73:1005 (1984).
D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire, Human breast cancer:correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science 235:177 (1987).
S. J. Stower, R. W. Wiseman, J. M. Ward, E. C. Miller, J. A. Miller, M. W. Anderson, and A. Eva, Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fisher 344 rats, Carcinogenesis 9:271 (1988).
H. Van der Putten, W. Quint, J. Van Raaji, E. R. Maandag, I. M. Verma, and A. Berns, M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors, Cell. 24:729 (1981).
M. Van Lohuizen, S. Verbeek, P. Krimpenfort, J. Domen, C. Saris, T. Radaszkiewicz, and A. Berns, Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors, Cell. 56:673 (1989).
M. Vogt, Properties of “Mink cell focus-inducing” (MCF) virus isolated from spontaneous lymphoma lines of BALB/c mice carrying Moloney leukemia virus as an endogenous virus, Virology 93:226 (1979).
J. M. Ward, D. G. Goodman, R. A. Squire, K. C. Chu, and M. S. Linhart, Neoplastic and nonneoplastic lesions in aging (C57BL/6NxC3H/HeN)F1 (B6C3F1) J. Natl. Cancer Inst. 63:849 (1979).
I. B. Weinstein, The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatments-Twenty-seventh G.H.A. Clowes memorial award lecture, Cancer Res. 48:4135 (1988).
R. W. Wiseman, S. J. Stowers, E. C. Miller, M. W. Anderson, and J. A. Miller, Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3F1 mouse, Proc. Natl. Acad. Sci. USA 83:5825 (1986).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dragani, T.A., Manenti, G., Colombo, B.M., Porta, G.D. (1991). Genetic Susceptibility to Murine Hepatocarcinogenesis. In: Columbano, A., Feo, F., Pascale, R., Pani, P. (eds) Chemical Carcinogenesis 2. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3694-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3694-9_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6642-3
Online ISBN: 978-1-4615-3694-9
eBook Packages: Springer Book Archive